[1]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2019/34725,2019,A1Locationinpatent:Page/Pagecolumn110
121629-14-9
141023-00-9
1204296-05-8
1434141-84-0
22515-17-9
84131-42-0
1193-30-2 | 6-Azaspiro[3.4]octan-5-one | AA000IGG | MFCD19219361
119426-82-3 | 2-Mercapto-3-pyridin-3-ylquinazolin-4(3h)-one | AA000INY | MFCD00113288
1227002-03-0 | Methyl 2-amino-5-chloropyridine-4-carboxylate | AA000IY0 | MFCD22375099
1227597-53-6 | 4-Bromo-2,3-difluoropyridine | AA000JBF | MFCD16609910
1228690-19-4 | [1,1'-Biphenyl]-4-acetic acid, 4'-[4-[[[(1R)-1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]- | AA000JKV | MFCD20486575
123-45-5 | Acetic acid, 2,2'-sulfonylbis- | AA000JUE | MFCD00054503
1232838-31-1 | Methyl 4-bromo-5-methyl-1h-pyrazole-3-carboxylate | AA000K6D | MFCD08056667
1234615-95-2 | [1,2,4]Triazolo[4,3-a]pyridine-5-carboxylic acid | AA000KIV | MFCD17015979
1235865-77-6 | 2-((1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoic acid | AA000KR4 | MFCD28129979
123910-26-9 | Boc-d-1,2,3,4-tetrahydronorharman-3-carboxylic acid | AA000L54 | MFCD00672321